Compare Fiserv Inc. Common Stock (FISV) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiserv Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Fiserv Inc. Common Stock trades at $46.18 (market cap $24.81B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Fiserv Inc. Common Stock is far larger — about 2.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Fiserv Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| FISV | RDY | |
|---|---|---|
Market Cap | $24.81B | $10.78B |
Volume | 4,091,234 | 2,724,343 |
Sector | Technology | Health |
52-Week High | $126.54 | $15.38 |
52-Week Low | $44.36 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.60B | $10.68B |
Dividend Yield | — | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiserv Inc. Common Stock
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
